Skip to main content

Clinical Trial Results

Search

Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: Effects Of Interleukin-6 Inhibition With Ziltivekimab On Biomarkers Of Inflammation Among Patients At High Risk For Atherosclerotic Events

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [6.47 MB]

Disclosures: TBD